Start for free
Start for free
SC

SVE Capital

North America, California, United States, Palo Alto

Description

SVE Capital is an investment Firm.

Investor Profile

SVE Capital has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (33%)
  • Seed (33%)
  • Series A (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Genetics
  • Agriculture
  • Artificial Intelligence (Ai)
  • Industrial Engineering
  • Machine Learning
  • Meat And Poultry
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SVE Capital frequently co-invest with?

Richard King Mellon Foundation
Richard King Mellon Foundation
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 2
EC
Euclidean Capital
North America, New York, United States, New York
Co-Investments: 2
Catalio Capital Management
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Boston Scientific
Boston Scientific
North America, Massachusetts, United States, Marlborough
Co-Investments: 2
AC
Ascendum Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF)
North America, California, United States, San Francisco
Co-Investments: 4
Morgenthaler Ventures
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Citta Capital
Citta Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Action Potential Venture Capital
Action Potential Venture Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2

What are some of recent deals done by SVE Capital?

SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownJan 19, 2023
Amount Raised: $80,000,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownJan 27, 2021
Amount Raised: $64,000,000
SwineTech

Solon, Iowa, United States

SwineTech bridges the gap between producers and pigs through artificial intelligence and sensor-based technologies.

AgricultureArtificial Intelligence (AI)Industrial EngineeringMachine LearningMeat and PoultryMechanical Engineering
Series AMar 13, 2020
Amount Raised: $5,000,000
Valitor

Berkeley, California, United States

Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..

BiotechnologyDeveloper ToolsMedicalTherapeutics
Series ASep 20, 2018
Amount Raised: $2,520,000
WaHa

Fremont, California, United States

Revolutionary platform for solid desiccant regeneration improves energy efficiency and carbon emissions by 50% for HVAC and AWG applications

AgTechCleanTechHeating, Ventilation, and Air Conditioning (HVAC)Water
SeedSep 1, 2018
Amount Raised: $3,600,000
DNALite Therapeutics

San Francisco, California, United States

DNALite Therapeutics is an early-stage preclinical biotechnology company.

BiotechnologyGeneticsHealth Care
SeedAug 8, 2018
Amount Raised: $1,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator